HK1102308A1 - Delta-9-tetrahydrocannabinol detection method - Google Patents

Delta-9-tetrahydrocannabinol detection method

Info

Publication number
HK1102308A1
HK1102308A1 HK07109716A HK07109716A HK1102308A1 HK 1102308 A1 HK1102308 A1 HK 1102308A1 HK 07109716 A HK07109716 A HK 07109716A HK 07109716 A HK07109716 A HK 07109716A HK 1102308 A1 HK1102308 A1 HK 1102308A1
Authority
HK
Hong Kong
Prior art keywords
cannabis
testing
delta
employing
conjugate
Prior art date
Application number
HK07109716A
Other languages
English (en)
Inventor
Jehanli Ahmed Mohammed Taki
Hand Christopher William
Original Assignee
Cozart Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cozart Bioscience Ltd filed Critical Cozart Bioscience Ltd
Publication of HK1102308A1 publication Critical patent/HK1102308A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • G01N33/526Multi-layer analytical elements the element being adapted for a specific analyte
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Glass Compositions (AREA)
  • Vending Machines For Individual Products (AREA)
  • Tone Control, Compression And Expansion, Limiting Amplitude (AREA)
  • Reverberation, Karaoke And Other Acoustics (AREA)
HK07109716A 2004-07-02 2007-09-06 Delta-9-tetrahydrocannabinol detection method HK1102308A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0414898A GB2404023B (en) 2004-07-02 2004-07-02 Delta-9-tetrahydrocannabinol detection method
PCT/GB2005/050099 WO2006003472A1 (en) 2004-07-02 2005-07-01 Delta-9-tetrahydrocannabinol detection method

Publications (1)

Publication Number Publication Date
HK1102308A1 true HK1102308A1 (en) 2007-11-16

Family

ID=32843498

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07109716A HK1102308A1 (en) 2004-07-02 2007-09-06 Delta-9-tetrahydrocannabinol detection method

Country Status (10)

Country Link
US (1) US7790400B2 (de)
EP (1) EP1825262B1 (de)
CN (1) CN1981193B (de)
AT (1) ATE408831T1 (de)
AU (1) AU2005258886B2 (de)
DE (1) DE602005009863D1 (de)
ES (1) ES2311994T3 (de)
GB (1) GB2404023B (de)
HK (1) HK1102308A1 (de)
WO (1) WO2006003472A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404022B (en) 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
GB2404023B (en) 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method
CN101495865B (zh) * 2005-05-20 2015-01-28 北京玛诺生物制药有限公司 口腔流体快速免疫层析检测
CN101438163B (zh) * 2006-05-09 2013-05-29 皇家飞利浦电子股份有限公司 利用磁场检测样品中的靶分子
CN101078715B (zh) * 2007-06-28 2010-12-08 艾博生物医药(杭州)有限公司 一种标准品溶液及其配制方法和应用
GB0725234D0 (en) * 2007-12-24 2008-02-06 Oxtex Ltd Electrochemical assays
KR101029306B1 (ko) 2010-07-23 2011-04-14 대한민국 대마 대사체 분석방법
SG194892A1 (en) * 2011-05-12 2013-12-30 Univ Rice William M Bio-nano-chips for on-site drug screening
ES2523682B1 (es) * 2011-06-27 2016-05-09 V.P. Pharma Baru, S.L. Sistema para la detección de drogas de abuso
US10408786B2 (en) 2012-06-14 2019-09-10 ChemiSensor, LLP Distributable chemical sampling and sensing system
WO2014051998A1 (en) 2012-09-28 2014-04-03 Clontech Laboratories, Inc. Lateral flow assays for tagged analytes
US20150369830A1 (en) * 2013-01-30 2015-12-24 Thcer Llc Articles and methods for rapid thc detection
US9970950B1 (en) 2014-03-09 2018-05-15 Hound Labs, Inc. Method and apparatus for detecting acute use of target substance(s)
US10653787B2 (en) 2014-03-18 2020-05-19 Izun Pharmaceuticals Corp Water-based cannabinoid and opioid compositions
CA2850998A1 (en) * 2014-04-18 2015-10-18 Thc Breathalyzer, Inc. Cannabis drug detection device
GB2528657B (en) * 2014-07-24 2019-03-13 Intelligent Fingerprinting Ltd Sample analysing device
US10331275B2 (en) 2014-07-31 2019-06-25 Hewlett-Packard Development Company, L.P. Process image according to mat characteristic
US9726684B1 (en) 2015-01-18 2017-08-08 Hound Labs, Inc. Compositions for target substance detection and measurement
US10254298B1 (en) 2015-03-25 2019-04-09 National Technology & Engineering Solutions Of Sandia, Llc Detection of metabolites for controlled substances
AU2016263784A1 (en) * 2015-05-20 2017-10-12 Agrivida, Inc. Processes for increasing extraction of enzymes from animal feed and measuring activity of the same
US9817006B2 (en) * 2015-06-19 2017-11-14 Amy J. Reisinger Rapid and sensitive method of forensic toxicology in post-mortem subjects using oral fluid testing
US20170023453A1 (en) * 2015-07-24 2017-01-26 Washington State University Particle-based drug detection methods
US11726102B2 (en) 2015-07-24 2023-08-15 Washington State University Particle-based drug detection method and device embodiments
US9933445B1 (en) 2016-05-16 2018-04-03 Hound Labs, Inc. System and method for target substance identification
US10458963B2 (en) 2016-06-08 2019-10-29 Kathleen Stitzlein Quantitative HPTLC cannabinoid field testing device and method
US9921234B1 (en) 2016-06-17 2018-03-20 Hound Labs, Inc. Compositions and methods for detection of target constituent in exhaled breath
US10981174B1 (en) 2016-08-04 2021-04-20 National Technology & Engineering Solutions Of Sandia, Llc Protein and nucleic acid detection for microfluidic devices
US11712200B2 (en) 2017-04-28 2023-08-01 University of Pittsburgh—of the Commonwealth System of Higher Education Nanostructure-based cannabinoid sensor
US11026596B1 (en) 2017-05-19 2021-06-08 Hound Labs, Inc. Detection and measurement of target substance in exhaled breath
EP3655160A4 (de) 2017-07-19 2021-04-07 Evanostics, LLC Kartuschen zur oralen flüssigkeitsanalyse und verwendungsverfahren
US11187711B1 (en) 2017-09-11 2021-11-30 Hound Labs, Inc. Analyte detection from breath samples
EP3724636A4 (de) 2017-12-15 2021-08-18 Evanostics, LLC Optischer leser für analytprüfung
US11426097B1 (en) * 2018-10-17 2022-08-30 Hound Labs, Inc. Rotary valve assemblies and methods of use for breath sample cartridge systems
US20200245898A1 (en) 2019-01-31 2020-08-06 Hound Labs, Inc. Single-use Microfluidic Cartridge for Detection of Target Chemical Presence in Human Breath
WO2020167828A1 (en) 2019-02-11 2020-08-20 Giner, Inc. Method and system for detection and/or quantification of delta-9-tetrahydrocannabinol in exhaled breath
US11977086B2 (en) 2019-03-21 2024-05-07 Hound Labs, Inc. Biomarker detection from breath samples
US20210003488A1 (en) * 2019-07-03 2021-01-07 Pinpoint Testing, Llc Ready-to-extract platforms for chemical analysis and quantification of unknown samples using spiked matrix standards
US11493451B2 (en) * 2019-12-23 2022-11-08 Palo Alto Research Center Incorporated Colorimetric drug test strip using porous support material
US11933731B1 (en) 2020-05-13 2024-03-19 Hound Labs, Inc. Systems and methods using Surface-Enhanced Raman Spectroscopy for detecting tetrahydrocannabinol
US11806711B1 (en) 2021-01-12 2023-11-07 Hound Labs, Inc. Systems, devices, and methods for fluidic processing of biological or chemical samples using flexible fluidic circuits

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067774A (en) 1971-05-14 1978-01-10 Syva Company Compounds for enzyme amplification assay
US5643732A (en) * 1971-05-20 1997-07-01 Strahilevitz; Meir Immunological assay methods
US3996344A (en) 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4041076A (en) 1974-10-23 1977-08-09 Hoffmann-La Roche Inc. Immunoassay for pharmacologically active phenethylamines
US4016146A (en) 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US4329281A (en) 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
US4771005A (en) * 1983-06-27 1988-09-13 Erez Forensic Technology Ltd. Reagents, test kits and methods for the detection of cannabinoids
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
US4868132A (en) 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US5144030A (en) * 1987-02-17 1992-09-01 Abbott Laboratories Fluorescene polarization immunoassay for tetrahydrocannabinoids
ES2184734T3 (es) 1987-04-27 2003-04-16 Inverness Medical Switzerland Dispositivo de prueba analitica para realizar ensayos de union especifica.
US4843020A (en) * 1988-01-14 1989-06-27 Woodford W James Method for detecting tetrahydrocannabinol in human urine involving melanin precipitation
US5026827A (en) 1988-09-02 1991-06-25 Matsushita Electric Industrial Co., Ltd. Amphetamine-protein complex as immunogen for obtaining antibodies specific to methamphetamine
ES2079368T3 (es) 1988-10-28 1996-01-16 Abbott Lab Metodo y reactivos para detectar anfetaminas y/o d-meta-anfetaminas en muestras biologicas.
US5248791A (en) 1989-04-10 1993-09-28 Abbott Laboratories Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
US5279955A (en) * 1991-03-01 1994-01-18 Pegg Randall K Heterofunctional crosslinking agent for immobilizing reagents on plastic substrates
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
KR0155608B1 (ko) 1995-07-14 1998-12-01 박홍기 원적외선 방사성 폴리에스테르 섬유의 제조방법
GB2339615B (en) 1998-07-14 2001-02-07 Cozart Bioscience Ltd Screening device and method of screening an immunoassay test
AU765221B2 (en) * 1999-03-22 2003-09-11 Pfizer Inc. Resorcinol derivatives
GB2361473C (en) 2000-03-08 2005-06-28 Microgenics Corp Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
US6534325B1 (en) 2000-06-30 2003-03-18 Roche Diagnostics Corporation Immunoassay for the detection of amphetamines, methamphetamines and methylenedioxy designer amphetamines
SE0002820L (sv) * 2000-08-04 2002-02-05 Jordanian Pharmaceutical Mfg & Medicinskt kit
US6472228B2 (en) 2000-12-04 2002-10-29 Lifepoint, Inc. Composition and methods for synthesis of novel tracers for detecting amphetamine and methamphetamine in samples
US7169907B2 (en) 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
GB0405999D0 (en) 2004-03-17 2004-04-21 Cozart Bioscience Ltd Procedure for manufacture of strips for lateral flow immunochromatographic devices
GB2404022B (en) 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
GB2404023B (en) * 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method

Also Published As

Publication number Publication date
ATE408831T1 (de) 2008-10-15
CN1981193B (zh) 2012-02-01
WO2006003472A1 (en) 2006-01-12
US20090017555A1 (en) 2009-01-15
AU2005258886B2 (en) 2007-10-11
GB2404023A8 (en) 2005-01-20
AU2005258886A1 (en) 2006-01-12
US7790400B2 (en) 2010-09-07
GB2404023A (en) 2005-01-19
GB2404023B (en) 2005-07-06
EP1825262B1 (de) 2008-09-17
CN1981193A (zh) 2007-06-13
GB0414898D0 (en) 2004-08-04
ES2311994T3 (es) 2009-02-16
DE602005009863D1 (de) 2008-10-30
EP1825262A1 (de) 2007-08-29

Similar Documents

Publication Publication Date Title
GB2404023B (en) Delta-9-tetrahydrocannabinol detection method
WO2005093414A3 (en) Assay devices utilizing chemichromic dyes
WO2006089027A3 (en) Lateral flow test kit and method for detecting an analyte
WO2008030546A3 (en) Lateral flow test strip with migrating label
WO2005050167A3 (en) Rapid sample collection and analysis device
Pil et al. Current developments in drug testing in oral fluid
IL151570A0 (en) Method for diagnosing immunologic food sensitivity
WO2009094058A3 (en) Real-time, single-step bioassay using nanoplasmonic resonator with ultra-high sensitivity
ITCZ20020002A1 (it) Dispositivo e metodo per il rilevamento simultaneo di differenti anticorpi e antigeni in campioni clinici, alimentari ed ambientali
MX2010013692A (es) Deteccion de uso de cannabis.
HRP20140675T1 (hr) Elisa za vegf
EP1789793A4 (de) Kombinationstest für alkohol und drogen
WO2006000920A3 (en) Dimensional analysis of saccharide conjugates with gpc & sec-mals
BRPI0408255A (pt) sistema de processamento de sinal e método
RU2013118695A (ru) Устройства, способы и наборы для иммунохроматографии
DE60316471D1 (de) Sich selbst kalibrierende durchflusstestvorrichtungen
WO2006083258A3 (en) Method and apparatus of quantitative assays
WO2003023051A3 (en) Lateral flow test format for enzyme assays
EP1494030A3 (de) Lösung zur Vorbehandlung eines Grippevirentests basierend auf Immunchromatographie
WO2008026102A3 (en) Detection of hydrogen peroxide released by enzyme-catalyzed oxidation of an analyte
AR050213A1 (es) Ensayo de diagnostico ileitis
WO2005116611A3 (en) Flow assay device comprising dry reagent cake
WO2007063326A3 (en) Assay device and method
AU2003215467A1 (en) Method and device for predicting cardiovascular events
AR018821A1 (es) Procedimiento para la determinacion de antibioticos con nucleo beta-lactama en un liquido biologico

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200701